These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24113347)

  • 1. Similar prevalence of expanded CGG repeat lengths in the fragile X mental retardation I gene among infertile women and among women with proven fertility: a prospective study.
    De Geyter C; M'Rabet N; De Geyter J; Zürcher S; Moffat R; Bösch N; Zhang H; Heinimann K
    Genet Med; 2014 May; 16(5):374-8. PubMed ID: 24113347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
    Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
    Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low and High-Normal
    Nunes ACV; Trevisan CM; Peluso C; Loureiro FA; Dias AT; Rincon D; Fonseca FLA; Christofolini DM; Laganà AS; Montagna E; Barbosa CP; Bianco B
    DNA Cell Biol; 2024 Aug; 43(8):414-424. PubMed ID: 38888596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve.
    Pastore LM; Young SL; Baker VL; Karns LB; Williams CD; Silverman LM
    Reprod Sci; 2012 Nov; 19(11):1226-31. PubMed ID: 22581803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?
    Gleicher N; Weghofer A; Oktay K; Barad DH
    Acta Obstet Gynecol Scand; 2009; 88(9):1024-30. PubMed ID: 19642041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the number of CGG repeats and serum level of anti-Müllerian hormone in women without FMR1 premutation.
    Choe SA; Kim KC; Lee JY; Kim CH; Hwang D; Jee BC
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):275-8. PubMed ID: 23731704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort study.
    Barad DH; Darmon S; Weghofer A; Latham GJ; Filipovic-Sadic ; Wang Q; Kushnir VA; Albertini DF; Gleicher N
    Reprod Biol Endocrinol; 2017 Apr; 15(1):34. PubMed ID: 28454580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency.
    Voorhuis M; Onland-Moret NC; Janse F; Ploos van Amstel HK; Goverde AJ; Lambalk CB; Laven JS; van der Schouw YT; Broekmans FJ; Fauser BC;
    Hum Reprod; 2014 Jul; 29(7):1585-93. PubMed ID: 24812319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone.
    Gleicher N; Weghofer A; Barad DH
    Fertil Steril; 2009 May; 91(5):1700-6. PubMed ID: 18384775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age.
    Kline JK; Kinney AM; Levin B; Brown SA; Hadd AG; Warburton D
    Menopause; 2014 Jul; 21(7):740-8. PubMed ID: 24423935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a fragile X messenger ribonucleoprotein 1 (FMR1) mRNA gain-of-function toxicity mechanism contributing to the pathogenesis of fragile X-associated premature ovarian insufficiency.
    Rosario R; Stewart HL; Choudhury NR; Michlewski G; Charlet-Berguerand N; Anderson RA
    FASEB J; 2022 Nov; 36(11):e22612. PubMed ID: 36250920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does theFMR1 gene affect IVF success?
    Pastore LM; Christianson MS; McGuinness B; Vaught KC; Maher JY; Kearns WG
    Reprod Biomed Online; 2019 Apr; 38(4):560-569. PubMed ID: 30711457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of normal-range FMR1 repeat length or genotypes and reproductive parameters.
    Maslow BS; Davis S; Engmann L; Nulsen JC; Benadiva CA
    J Assist Reprod Genet; 2016 Sep; 33(9):1149-55. PubMed ID: 27189053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of FMR1 gene association with ovarian dysfunction in a sample from the Basque Country.
    Barasoain M; Barrenetxea G; Huerta I; Télez M; Carrillo A; Pérez C; Criado B; Arrieta I
    Gene; 2013 May; 521(1):145-9. PubMed ID: 23537988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CGG Repeats in the 5'UTR of FMR1 RNA Regulate Translation of Other RNAs Localized in the Same RNA Granules.
    Rovozzo R; Korza G; Baker MW; Li M; Bhattacharyya A; Barbarese E; Carson JH
    PLoS One; 2016; 11(12):e0168204. PubMed ID: 28005950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat level.
    Pastore LM; McMurry TL; Williams CD; Baker VL; Young SL
    J Assist Reprod Genet; 2014 Oct; 31(10):1295-301. PubMed ID: 24938362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGG repeat length and AGG interruptions as indicators of fragile X-associated diminished ovarian reserve.
    Lekovich J; Man L; Xu K; Canon C; Lilienthal D; Stewart JD; Pereira N; Rosenwaks Z; Gerhardt J
    Genet Med; 2018 Sep; 20(9):957-964. PubMed ID: 29267266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function.
    Karimov CB; Moragianni VA; Cronister A; Srouji S; Petrozza J; Racowsky C; Ginsburg E; Thornton KL; Welt CK
    Hum Reprod; 2011 Aug; 26(8):2077-83. PubMed ID: 21646280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can FMR1 CGG repeat lengths predict the outcome in ICSI cycles?
    Cogendez E; Ozkaya E; Eser AÇ; Eken M; Karaman A
    Ginekol Pol; 2022; 93(9):735-741. PubMed ID: 35072235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
    Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
    Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.